Navana Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '25 Jan 28, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	4,877	9,377	12,546	-	-	-
Market Cap Growth	-44.67%	-25.26%	-	-	-	-
Enterprise Value	10,125	13,845	15,739	-	-	-
Last Close Price	45.40	85.03	111.99	-	-	-
PE Ratio	11.64	23.18	35.15	-	-	-
PS Ratio	0.66	1.36	2.20	-	-	-
PB Ratio	1.04	2.06	2.87	-	-	-
P/TBV Ratio	1.18	2.06	2.87	-	-	-
P/OCF Ratio	6.95	13.26	64.76	-	-	-
EV/Sales Ratio	1.37	2.01	2.76	-	-	-
EV/EBITDA Ratio	7.48	11.90	16.29	-	-	-
EV/EBIT Ratio	8.91	13.96	20.83	-	-	-
Debt / Equity Ratio	1.19	1.18	0.99	0.86	0.45	0.31
Debt / EBITDA Ratio	4.11	4.46	4.48	4.09	3.42	2.82
Debt / FCF Ratio	-	-	-	-	-	5.32
Asset Turnover	0.70	0.66	0.68	0.77	0.75	-
Inventory Turnover	1.96	1.96	2.28	2.47	2.27	-
Quick Ratio	0.22	0.20	0.26	0.19	0.31	0.39
Current Ratio	0.91	0.87	0.99	0.88	1.15	1.31
Return on Equity (ROE)	9.30%	9.06%	9.09%	8.07%	6.32%	-
Return on Assets (ROA)	6.69%	5.93%	5.67%	5.80%	4.52%	-
Return on Capital (ROIC)	7.43%	6.65%	6.22%	6.31%	4.92%	-
Earnings Yield	8.62%	4.31%	2.85%	-	-	-
FCF Yield	-12.34%	-6.67%	-11.19%	-	-	-
Dividend Yield	3.08%	1.65%	1.16%	-	-	-
Payout Ratio	32.14%	33.83%	31.70%	-	-	-
Buyback Yield / Dilution	-1.72%	-8.05%	-23.91%	-	-	-
Total Shareholder Return	1.37%	-6.40%	-22.75%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.